204 related articles for article (PubMed ID: 17054420)
1. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.
Glunde K; Serkova NJ
Pharmacogenomics; 2006 Oct; 7(7):1109-23. PubMed ID: 17054420
[TBL] [Abstract][Full Text] [Related]
2. Choline metabolism in cancer: implications for diagnosis and therapy.
Glunde K; Jacobs MA; Bhujwalla ZM
Expert Rev Mol Diagn; 2006 Nov; 6(6):821-9. PubMed ID: 17140369
[TBL] [Abstract][Full Text] [Related]
3. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
[TBL] [Abstract][Full Text] [Related]
5. MR evaluation of response to targeted treatment in cancer cells.
Podo F; Canevari S; Canese R; Pisanu ME; Ricci A; Iorio E
NMR Biomed; 2011 Jul; 24(6):648-72. PubMed ID: 21387442
[TBL] [Abstract][Full Text] [Related]
6. Alterations of choline phospholipid metabolism in ovarian tumor progression.
Iorio E; Mezzanzanica D; Alberti P; Spadaro F; Ramoni C; D'Ascenzo S; Millimaggi D; Pavan A; Dolo V; Canevari S; Podo F
Cancer Res; 2005 Oct; 65(20):9369-76. PubMed ID: 16230400
[TBL] [Abstract][Full Text] [Related]
7. The role of choline in prostate cancer.
Awwad HM; Geisel J; Obeid R
Clin Biochem; 2012 Dec; 45(18):1548-53. PubMed ID: 22921309
[TBL] [Abstract][Full Text] [Related]
8. Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.
Inazu M
Biopharm Drug Dispos; 2014 Nov; 35(8):431-49. PubMed ID: 24532461
[TBL] [Abstract][Full Text] [Related]
9. Choline metabolism-based molecular diagnosis of cancer: an update.
Glunde K; Penet MF; Jiang L; Jacobs MA; Bhujwalla ZM
Expert Rev Mol Diagn; 2015 Jun; 15(6):735-47. PubMed ID: 25921026
[TBL] [Abstract][Full Text] [Related]
10. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.
Morvan D; Demidem A; Papon J; De Latour M; Madelmont JC
Cancer Res; 2002 Mar; 62(6):1890-7. PubMed ID: 11912170
[TBL] [Abstract][Full Text] [Related]
11. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
[TBL] [Abstract][Full Text] [Related]
12. Choline phospholipid metabolism: a target in cancer cells?
Ackerstaff E; Glunde K; Bhujwalla ZM
J Cell Biochem; 2003 Oct; 90(3):525-33. PubMed ID: 14523987
[TBL] [Abstract][Full Text] [Related]
13. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.
Glunde K; Ackerstaff E; Mori N; Jacobs MA; Bhujwalla ZM
Mol Pharm; 2006; 3(5):496-506. PubMed ID: 17009848
[TBL] [Abstract][Full Text] [Related]
14. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
Le Tourneau C; Vidal L; Siu LL
Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
[TBL] [Abstract][Full Text] [Related]
15. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.
Glunde K; Raman V; Mori N; Bhujwalla ZM
Cancer Res; 2005 Dec; 65(23):11034-43. PubMed ID: 16322253
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets.
Rodríguez-González A; Ramírez de Molina A; Benítez-Rajal J; Lacal JC
Prog Cell Cycle Res; 2003; 5():191-201. PubMed ID: 14593713
[TBL] [Abstract][Full Text] [Related]
17. Targeting Phospholipid Metabolism in Cancer.
Cheng M; Bhujwalla ZM; Glunde K
Front Oncol; 2016; 6():266. PubMed ID: 28083512
[TBL] [Abstract][Full Text] [Related]
18. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
19. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic functional duality of cancer genes.
Stepanenko AA; Vassetzky YS; Kavsan VM
Gene; 2013 Oct; 529(2):199-207. PubMed ID: 23933273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
